{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:48:37Z","timestamp":1792154917115,"version":"4.4.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Brachytherapy (BT) is favored over external beam radiation therapy (EBRT) for certain tumors with modest ionizing damage. However, the biological effect of BT in glioblastoma remains uncertain. Thus, this study aimed to compare BT and EBRT in glioblastoma treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>BT cell culture templates ensured equal in vitro doses between BT and EBRT. The effects of EBRT and BT on GL261 glioblastoma cells were detected by CCK8 assay, colony formation assay, and flow cytometry. In addition, cellular reactive oxygen species (ROS) levels and mitochondrial membrane potential were measured. Western blotting was used to verify the mechanisms underlying regulated cell death, including apoptosis and ferroptosis. A GL261 xenograft model was also constructed for in vivo validation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>BT significantly reduced GL261 viability and proliferation while promoting apoptosis. It also significantly increased ROS levels and altered MMP. Moreover, BT upregulated the level of \u03b3-H2AX (DNA damage), GPX4, SLC7A11 (antioxidant defense), and PTGS2 (ferroptosis marker), indicating BT-induced ferroptosis and an adaptive cellular antioxidant response. In xenografts, BT significantly inhibited tumor growth, decreased CD31 expression levels indicating impaired angiogenesis, and increased HIF-1\u03b1 levels reflecting exacerbated tumor hypoxia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>BT effectively induces oxidative stress, DNA damage, and ferroptosis in glioblastoma. It also triggers a robust antioxidant defense response while influencing angiogenesis and the hypoxic tumor microenvironment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_937_26","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T08:00:08Z","timestamp":1786953608000},"page":"715-726","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Revisiting brachytherapy: Balancing cell death and antioxidant defense in glioblastoma treatment"],"prefix":"10.4103","volume":"22","author":[{"given":"Xueda","family":"Li","sequence":"first","affiliation":[{"name":"Department of the Interventional Medical Center, The Affiliated Hospital of Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of the Interventional Medical Center, The Affiliated Hospital of Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenshe","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Medicine, Cancer Institute of the Affiliated Hospital of Qingdao University and Qingdao Cancer Institute, Qingdao, China"},{"name":"Department of the Medical Science and Technology Innovation Center, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of the Interventional Medical Center, The Affiliated Hospital of Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of the Interventional Medical Center, The Affiliated Hospital of Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy Technology Center, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongming","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Medicine, Cancer Institute of the Affiliated Hospital of Qingdao University and Qingdao Cancer Institute, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congxiao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of the Interventional Medical Center, The Affiliated Hospital of Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokun","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of the Interventional Medical Center, The Affiliated Hospital of Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"R1-20261016","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(21)00233-6","article-title":"Contemporary radiotherapy: Present and future","volume":"398","author":"Chandra","year":"2021","journal-title":"Lancet"},{"key":"R2-20261016","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.4103\/jcrt.jcrt_594_21","article-title":"Comparative study of concurrent conventional chemoradiotherapy versus hypofractionated chemoradiotherapy in newly diagnosed glioblastoma multiforme postoperative patients","volume":"19","author":"Khatri","year":"2023","journal-title":"J Cancer Res Ther"},{"key":"R3-20261016","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000493058","article-title":"Adverse radiation effects","volume":"34","author":"Cheok","year":"2019","journal-title":"Prog Neurol Surg"},{"key":"R4-20261016","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.addr.2016.09.002","article-title":"Advancements in brachytherapy","volume":"109","author":"Tanderup","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"issue":"(Suppl 6)","key":"R5-20261016","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1093\/neuonc\/noac094","article-title":"Spinal brachytherapy","volume":"24","author":"Mao","year":"2022","journal-title":"Neuro Oncol"},{"key":"R6-20261016","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4103\/jcrt.jcrt_564_23","article-title":"Salvage SABR for a locally recurrent prostate cancer post 125I seed brachytherapy and ADT failure","volume":"21","author":"Zade","year":"2025","journal-title":"J Cancer Res Ther"},{"key":"R7-20261016","doi-asserted-by":"crossref","first-page":"1176083","DOI":"10.3389\/fcell.2023.1176083","article-title":"I-125 seeds brachytherapy combined with immunotherapy for MET amplification in non-small cell lung cancer from clinical application to related lncRNA mechanism explore: A case report","volume":"11","author":"Yang","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"R8-20261016","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ijrobp.2022.12.049","article-title":"BRACHY: A randomized trial to evaluate symptom improvement in advanced non-small cell lung cancer treated with external beam radiation with or without high-dose-rate intraluminal brachytherapy","volume":"116","author":"Sur","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R9-20261016","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.4103\/jcrt.jcrt_2638_22","article-title":"Computed tomography-guided radioactive iodine-125 seed implantation for liver malignancies in challenging locations","volume":"20","author":"Li","year":"2024","journal-title":"J Cancer Res Ther"},{"key":"R10-20261016","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4103\/jcrt.jcrt_1891_23","article-title":"Efficacy of radioactive 125I seed implantation in treating inoperable or refused operation head and neck cancers","volume":"20","author":"Zhang","year":"2024","journal-title":"J Cancer Res Ther"},{"key":"R11-20261016","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semcancer.2017.11.010","article-title":"Glioma epigenetics: From subclassification to novel treatment options","volume":"51","author":"Gusyatiner","year":"2018","journal-title":"Semin Cancer Biol"},{"key":"R12-20261016","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11912-009-0077-4","article-title":"Advances in the treatment of malignant gliomas","volume":"12","author":"Khasraw","year":"2010","journal-title":"Curr Oncol Rep"},{"key":"R13-20261016","doi-asserted-by":"crossref","first-page":"7990","DOI":"10.3390\/ijms25147990","article-title":"Glioma and peptidergic systems: Oncogenic and anticancer peptides","volume":"25","author":"S\u00e1nchez","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R14-20261016","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ccell.2021.01.006","article-title":"Proteogenomic and metabolomic characterization of human glioblastoma","volume":"39","author":"Wang","year":"2021","journal-title":"Cancer Cell"},{"key":"R15-20261016","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11060-022-04026-3","article-title":"Brachytherapy for central nervous system tumors","volume":"158","author":"Bander","year":"2022","journal-title":"J Neurooncol"},{"key":"R16-20261016","doi-asserted-by":"crossref","first-page":"110012","DOI":"10.1016\/j.radonc.2023.110012","article-title":"Brachytherapy is an effective and safe salvage option for re-irradiation in recurrent glioblastoma (rGBM): A systematic review","volume":"190","author":"Xiang","year":"2024","journal-title":"Radiother Oncol"},{"key":"R17-20261016","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.prro.2016.03.007","article-title":"Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline","volume":"6","author":"Cabrera","year":"2016","journal-title":"Pract Radiat Oncol"},{"key":"R18-20261016","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11060-018-03064-0","article-title":"Re-irradiation for recurrent glioblastoma (GBM): A systematic review and meta-analysis","volume":"142","author":"Kazmi","year":"2019","journal-title":"J Neurooncol"},{"key":"R19-20261016","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3171\/jns.1992.76.2.0179","article-title":"Selection bias, survival, and brachytherapy for glioma","volume":"76","author":"Florell","year":"1992","journal-title":"J Neurosurg"},{"key":"R20-20261016","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0360-3016(98)00159-X","article-title":"Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma","volume":"41","author":"Laperriere","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R21-20261016","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00006123-200208000-00009","article-title":"The brain tumor cooperative group NIH Trial 87-01: A randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine","volume":"51","author":"Selker","year":"2002","journal-title":"Neurosurgery"},{"key":"R22-20261016","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1186\/s12885-020-07086-8","article-title":"Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Cancer"},{"key":"R23-20261016","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1186\/s12885-022-09504-5","article-title":"Effect of neoadjuvant iodine-125 brachytherapy upon resection of glioma","volume":"22","author":"Wang","year":"2022","journal-title":"BMC Cancer"},{"key":"R24-20261016","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.brachy.2019.01.015","article-title":"The American Brachytherapy Society consensus statement on intraoperative radiation therapy","volume":"18","author":"Tom","year":"2019","journal-title":"Brachytherapy"},{"key":"R25-20261016","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11060-023-04523-z","article-title":"The role of GammaTile in the treatment of brain tumors: A technical and clinical overview","volume":"166","author":"Garcia","year":"2024","journal-title":"J Neurooncol"},{"key":"R26-20261016","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.brachy.2020.12.005","article-title":"First clinical implementation of GammaTile permanent brain implants after FDA clearance","volume":"20","author":"Ferreira","year":"2021","journal-title":"Brachytherapy"},{"key":"R27-20261016","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.brachy.2025.07.003","article-title":"A biologically effective dose-based framework for integrating LDR brachytherapy and EBRT in glioblastoma treatment","volume":"24","author":"Turner","year":"2025","journal-title":"Brachytherapy"},{"key":"R28-20261016","doi-asserted-by":"crossref","first-page":"11047","DOI":"10.3390\/ijms222011047","article-title":"Role of mitochondria in radiation responses: Epigenetic, metabolic, and signaling impacts","volume":"22","author":"Averbeck","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R29-20261016","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41422-019-0263-3","article-title":"The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression","volume":"30","author":"Lei","year":"2020","journal-title":"Cell Res"},{"key":"R30-20261016","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.7150\/jca.50789","article-title":"Clinical importance of ADC in the prediction of (125) I in the treatment for gliomas","volume":"12","author":"Wang","year":"2021","journal-title":"J Cancer"},{"key":"R31-20261016","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11060-023-04352-0","article-title":"Safety and efficacy of Cesium-131 brachytherapy for brain tumors","volume":"163","author":"Bander","year":"2023","journal-title":"J Neurooncol"},{"key":"R32-20261016","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13014-022-02141-z","article-title":"Comparative analysis of the prognosis of external beam radiation therapy (EBRT) and EBRT plus brachytherapy for glioblastoma multiforme: A SEER population-based study","volume":"17","author":"Yang","year":"2022","journal-title":"Radiat Oncol"},{"key":"R33-20261016","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11060-020-03612-7","article-title":"The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: A systematic review and evidence-based clinical practice guideline update","volume":"150","author":"Ziu","year":"2020","journal-title":"J Neurooncol"},{"key":"R34-20261016","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/neuonc\/noac188","article-title":"EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors","volume":"24","author":"Rud\u00e0","year":"2022","journal-title":"Neuro Oncol"},{"key":"R35-20261016","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1259\/bjr.71.845.9691890","article-title":"The clinical radiobiology of brachytherapy","volume":"71","author":"Dale","year":"1998","journal-title":"Br J Radiol"},{"key":"R36-20261016","doi-asserted-by":"crossref","first-page":"102913","DOI":"10.1016\/j.dnarep.2020.102913","article-title":"Restoration of ligatable \"clean\" double-strand break ends is the rate-limiting step in the rejoining of ionizing-radiation-induced DNA breakage","volume":"93","author":"Sasanuma","year":"2020","journal-title":"DNA Repair (Amst)"},{"key":"R37-20261016","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.3390\/molecules27051540","article-title":"DNA damage clustering after ionizing radiation and consequences in thve processing of chromatin breaks","volume":"27","author":"Mladenova","year":"2022","journal-title":"Molecules"},{"key":"R38-20261016","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/bab.2104","article-title":"The interplay of ROS and the PI3K\/Akt pathway in autophagy regulation","volume":"69","author":"Kma","year":"2022","journal-title":"Biotechnol Appl Biochem"},{"key":"R39-20261016","doi-asserted-by":"crossref","first-page":"101084","DOI":"10.1016\/j.redox.2018.101084","article-title":"ROS and the DNA damage response in cancer","volume":"25","author":"Srinivas","year":"2019","journal-title":"Redox Biol"},{"key":"R40-20261016","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41392-023-01720-0","article-title":"Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"R41-20261016","doi-asserted-by":"crossref","first-page":"e2207216","DOI":"10.1002\/advs.202207216","article-title":"Polydopamine nanoparticles targeting ferroptosis mitigate intervertebral disc degeneration via reactive oxygen species depletion, iron ions chelation, and GPX4 ubiquitination suppression","volume":"10","author":"Yang","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"R42-20261016","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s13238-021-00841-y","article-title":"Ferroptosis, radiotherapy, and combination therapeutic strategies","volume":"12","author":"Lei","year":"2021","journal-title":"Protein Cell"},{"key":"R43-20261016","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.radonc.2020.06.038","article-title":"Low doses of ionizing radiation activate endothelial cells and induce angiogenesis in peritumoral tissues","volume":"151","author":"Gil Marques","year":"2020","journal-title":"Radiother Oncol"},{"key":"R44-20261016","doi-asserted-by":"crossref","first-page":"e159839","DOI":"10.1172\/JCI159839","article-title":"Hypoxia-inducible factors: Cancer progression and clinical translation","volume":"132","author":"Wicks","year":"2022","journal-title":"J Clin Invest"},{"key":"R45-20261016","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-023-00848-6","article-title":"Targeting hypoxia-inducible factors: Therapeutic opportunities and challenges","volume":"23","author":"Yuan","year":"2024","journal-title":"Nat Rev Drug Discov"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_937_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:01:26Z","timestamp":1792152086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_937_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_937_26","relation":{},"ISSN":["1998-4138","0973-1482"],"issn-type":[{"value":"1998-4138","type":"print"},{"value":"0973-1482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"2026-06-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}